PI Industries Ltd - 523642 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for the Financial Results- March 31, 202322-05-2023
22-05-2023
PI Industries Ltd - 523642 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for the Financial Results- March 31, 202322-05-2023
PI Industries Ltd - 523642 - Audio Recording Of Analysts/Investors Call Pertaining To The Financial Results For The Quarter And Financial Year Ended March 31, 2023
Pursuant to Regulation 30 read with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the Analysts/Investors Call on the Audited Standalone and Audited Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2023 held on Friday, May 19, 2023 is available on the Company's website at https://www.piindustries.com/investor-relations/co-go/Concal-Transcript19-05-2023
PI Industries Results Earnings Call for Q4FY23
Conference Call with PI Industries Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.19-05-2023
Q4FY23 Quarterly & FY23 Annual Result Announced for PI Industries Ltd.
Agrochemicals company PI Industries announced Q4FY23 & FY23 results: Q4FY23: Overall 12% YoY revenue growth 15% growth in exports led by price, currency, and favourable product mix of ~17% offset by volume decrease of ~2% Domestic growth at 1% YoY is driven by a volume increase of ~2% offset by a price decrease of ~1% Gross margin improved on account of a favourable product mix 37% increase in PAT attributable to EBITDA growth despite higher depreciation Cash generated from operations before tax during Q4FY23 is Rs 5,729 million (Q4FY22 Rs 2,640 million) Trade working capital was reduced by Rs 2,237 million during Q4FY23 The board proposed a final dividend for FY23 of Rs 5.50 per share, aggregating to a total dividend for FY23 of Rs 10.00 per share FY23: Total capex for FY23 is Rs 3,385 million (FY22 Rs 3,204 million) Actual capex spend is in line with the plan A key focus of driving higher capacity utilisation by improving throughput Operating profit before working capital changes is Rs 15,522 million (FY22 Rs 12,314 million) Inventory levels reduced in terms of Days of Sales to approx. 79 days to Rs 13,976 million Improved working capital cycle to 79 days as of 31-Mar-23 vs. 103 days as on 31-Mar-22 Cash flow from operating activities is Rs 15,014 million (FY22 Rs 5,287 million) The surplus cash net of debt is Rs 32,343 million. QIP funds remained invested into deposits and debt mutual funds with SLR philosophy while final deployment aligned with PI’s longer-term growth strategy is underway. Capitalised PI Health Sciences (PIHS) for planned acquisitions and capacity build-up Result PDF19-05-2023
PI Industries Ltd - 523642 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Performance of the Company for the quarter and financial year ended March 31, 202318-05-2023
Large cap stock announces record date for 550% dividend, LIC held 2.88% stake in Q4
In today's closing session, PI Industries, a large-cap pesticide firm, had a market cap of 49,323.56 Cr.18-05-2023
PI Industries Ltd - 523642 - Submission Of Disclosure On Related Party Transactions For Half Year Ended March 31, 2023 Pursuant To Regulation 23(9) Of SEBI(LODR) Regulations, 2015.
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we are enclosing herewith the disclosures of related party transactions in accordance with the applicable accounting standards, for the half year ended March 31, 2023.18-05-2023